Education
About Us
Working with TipRanks
Follow Us
Fresenius Medical Care (FMS)
:FMS
Earnings Data
Report Date
Feb 24, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
0.56Last Year’s EPS
0.48Same Quarter Last Year
Moderate Sell
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflected an overall positive sentiment with strong organic revenue and operating income growth, significant contribution from phosphate binders, and continued savings from the FME25+ program. However, challenges such as low U.S. same-market treatment growth, earnings fluctuations in Value-Based Care, and unfavorable foreign exchange impacts were noted.Company Guidance
Strong Organic Revenue Growth
In the third quarter, the company realized strong organic revenue growth of 10%, with positive contributions from all three operating segments.
Operating Income Growth
Operating income growth increased for a third consecutive quarter and accelerated to 28%, driving a step change in profitability with the operating income margin expanding from 9.9% to 11.7%.
Phosphate Binders Contribution
The contribution from phosphate binders in the pharma business is expected to be around EUR 180 million for the full year, significantly above the initial expectation of EUR 100 million.
FME25+ Program Savings
Continued momentum in the FME25+ program generated a further EUR 47 million in sustainable savings in the quarter, bringing the total savings for 2025 to EUR 174 million.
Share Buyback Program
The company announced an initial share buyback of EUR 1 billion, with a first tranche of up to EUR 600 million having commenced in August.
Improved Patient Care Initiatives
Treatment adherence improved, and antimicrobial interventions reduced infection rates by 70%. Flu vaccination rates were 34% higher compared to the previous year.
FMS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
FMS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 04, 2025 | $26.35 | $24.29 | -7.82% |
Aug 05, 2025 | $24.94 | $24.42 | -2.09% |
May 06, 2025 | $25.14 | $26.90 | +7.00% |
Feb 25, 2025 | $22.87 | $23.01 | +0.61% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Fresenius Medical Care (FMS) report earnings?
Fresenius Medical Care (FMS) is schdueled to report earning on Feb 24, 2026, TBA (Confirmed).
What is Fresenius Medical Care (FMS) earnings time?
Fresenius Medical Care (FMS) earnings time is at Feb 24, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is FMS EPS forecast?
FMS EPS forecast for the fiscal quarter 2025 (Q4) is 0.56.